Delivery Order 75N93021D00014-75N93021F00002
- This is a $1,272,402.60 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Colorado State University for preclinical models of infectious diseases research. The award is part of NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract has a firm-fixed price structure and an ultimate completion date of August 2, 2025. Colorado State University, a public land-grant research...
- This task order, awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Colorado State University, funds the guaranteed minimum amount of $0.00 under the Preclinical Services for HIV Therapeutics contract vehicle. As part of the larger Preclinical Services for HIV Therapeutics IDIQ, Colorado State University will provide preclinical services in support of HIV therapeutic development to the National Institute of Allergy and Infectious Diseases....
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.28 million delivery order against the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract to Colorado State University Sponsored Programs Division. Colorado State University Sponsored Programs Division will perform Task A07 under the delivery order as the prime contractor. The work will be conducted in Fort...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $213,244 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity master IDIQ contract. Colorado State University Sponsored Programs Division, doing business as Sponsored Programs and representing parent company Colorado State University System, will perform in vitro assessments of antimicrobial activity as outlined in the...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Colorado State University on June 2, 2026, under the Preclinical Models of Infectious Diseases indefinite delivery contract for model development and in vivo screening of antivirals directed against select togaviruses, with a ceiling value of $993,995. The Preclinical Models of Infectious Diseases IDV, valued at $146.3 million with an ordering period through July 14, 2031, supports NIAID's mission to understand,...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Colorado State University (CSU) for the collection of metadata from in vivo studies performed under previous indefinite-delivery, indefinite-quantity (IDIQ) contract mechanisms. The contract has a ceiling value of $56,795.00 and runs through July 14, 2031. The contract does not have a set-aside designation. CSU's Sponsored Programs division, which has provided a...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Colorado State University on March 23, 2020, under the NIAID Preclinical Models of Infectious Diseases 2017–2024 parent IDIQ with a ceiling value of $1,545,556.08 to establish small animal models for screening monoclonal antibodies against SARS-CoV-2. The order was issued on a cost-no-fee basis to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in...
- This is a delivery order award under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery, indefinite-quantity (IDIQ) contract. The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded this $725,584 cost-no-fee contract to Colorado State University's Sponsored Programs division to develop a cryopreservation process for mosquito vectors of...
- This federal contract award, valued at $1,353,907, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Colorado State University's Sponsored Programs division. The purpose of the award is to conduct "Antimycobacterial Evaluation of Chemical Entities in Mouse Models." This task order falls under NIAID's larger "Animal Models of Infectious Diseases 2010-2017" IDIQ contract. The award does not have a set-aside designation. Colorado State University...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Colorado State University (CSU) for the development of "Advanced Small Animal Models for the Testing of Candidate Preventive Intervention Against Mycobacteria." The award, valued at $3,086,647, is a task order under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery/indefinite quantity (IDIQ)...
- Preclinical Services for HIV TherapeuticsMaster IDIQ
- 75N93021D00014Indefinite Delivery Contract
- 75N93021D00014-75N93021F00002Delivery Order
This delivery order from the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $14,945.99 to Colorado State University Sponsored Programs Division for work to be conducted from April to August 2021. The task order is issued against the Preclinical Services for HIV Therapeutics indefinite-delivery/indefinite-quantity contract vehicle and requires development and delivery of a quality assurance/quality control plan and participation in a task order initiation meeting to support NIAID's mission of conducting and supporting research on infectious and immune-mediated diseases. As the prime contractor, Colorado State University Sponsored Programs Division will perform the work in Fort Collins, Colorado on a cost-no-fee basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | 0$ | 5/1/23 | |
| Not listed | Not listed | $14.9k | 4/9/21 |